Proteus targets US oncology market with digital cancer pill debut

06:29 EST 28 Jan 2019 | Pharmaceutical Technology

A Silicon Valley company is testing ingestible pills embedded with sensors for cancer patients in a bid to bring digital...
Read More...

The post Proteus targets US oncology market with digital cancer pill debut appeared first on Pharmaceutical Technology.

Original Article: Proteus targets US oncology market with digital cancer pill debut

More From BioPortfolio on "Proteus targets US oncology market with digital cancer pill debut"